IRIS - Res&Arch Institutional Research Information System - Research & Archive

GRESELE, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.427
AS - Asia 9.717
EU - Europa 9.674
SA - Sud America 1.653
Continente sconosciuto - Info sul continente non disponibili 844
AF - Africa 234
OC - Oceania 10
Totale 35.559
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.097
SG - Singapore 4.292
IE - Irlanda 1.691
UA - Ucraina 1.654
HK - Hong Kong 1.639
RU - Federazione Russa 1.431
IT - Italia 1.400
BR - Brasile 1.223
CN - Cina 1.188
VN - Vietnam 1.007
SE - Svezia 804
DE - Germania 707
FR - Francia 619
FI - Finlandia 510
GB - Regno Unito 307
KR - Corea 287
TR - Turchia 271
BD - Bangladesh 232
IN - India 179
CA - Canada 166
AR - Argentina 147
IQ - Iraq 93
PL - Polonia 81
NL - Olanda 72
MX - Messico 71
JP - Giappone 70
ZA - Sudafrica 67
CO - Colombia 63
ES - Italia 62
UZ - Uzbekistan 60
AT - Austria 58
CH - Svizzera 58
PK - Pakistan 57
VE - Venezuela 55
EC - Ecuador 51
ID - Indonesia 51
SA - Arabia Saudita 48
BE - Belgio 47
PH - Filippine 35
CL - Cile 34
LB - Libano 34
MA - Marocco 33
MY - Malesia 26
PY - Paraguay 26
CZ - Repubblica Ceca 23
LT - Lituania 23
EG - Egitto 21
GR - Grecia 21
TN - Tunisia 21
BO - Bolivia 20
JO - Giordania 20
KE - Kenya 20
RO - Romania 18
JM - Giamaica 16
CR - Costa Rica 15
UY - Uruguay 15
AE - Emirati Arabi Uniti 14
KZ - Kazakistan 14
DZ - Algeria 13
EU - Europa 13
MK - Macedonia 13
PE - Perù 13
AL - Albania 12
NI - Nicaragua 12
AZ - Azerbaigian 10
IL - Israele 10
IR - Iran 10
NP - Nepal 10
OM - Oman 10
RS - Serbia 10
BG - Bulgaria 9
PS - Palestinian Territory 9
TH - Thailandia 9
HN - Honduras 8
HU - Ungheria 8
TT - Trinidad e Tobago 8
ET - Etiopia 7
PA - Panama 7
PT - Portogallo 7
GT - Guatemala 6
AU - Australia 5
BH - Bahrain 5
DO - Repubblica Dominicana 5
LY - Libia 5
SC - Seychelles 5
AO - Angola 4
BB - Barbados 4
CI - Costa d'Avorio 4
GA - Gabon 4
KW - Kuwait 4
SN - Senegal 4
SY - Repubblica araba siriana 4
TZ - Tanzania 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
CU - Cuba 3
EE - Estonia 3
HR - Croazia 3
LK - Sri Lanka 3
ME - Montenegro 3
Totale 34.657
Salva come PNG Salva come JPEG
Città #
Singapore 2.893
Chandler 1.786
Dublin 1.678
Hong Kong 1.635
San Jose 1.188
San Mateo 907
Jacksonville 902
Ashburn 787
Santa Clara 538
Boardman 533
Moscow 484
Dong Ket 467
Altamura 434
Medford 416
Princeton 415
Lauterbourg 390
Perugia 349
Lawrence 312
Wilmington 291
Beijing 274
Seoul 267
Ann Arbor 265
Des Moines 229
Andover 211
Los Angeles 207
Izmir 193
Munich 192
Ho Chi Minh City 188
New York 179
The Dalles 170
Saint Petersburg 139
Hanoi 119
Piscataway 112
São Paulo 103
Helsinki 96
Turku 80
Norwalk 77
Tokyo 67
Frankfurt am Main 64
Orem 64
Rome 60
Shanghai 57
Dallas 55
Redmond 55
Dearborn 54
Montreal 54
Houston 52
London 52
Woodbridge 52
Brooklyn 50
Denver 47
San Paolo di Civitate 46
Brussels 45
Rio de Janeiro 41
Johannesburg 40
Phoenix 40
Atlanta 39
Baghdad 39
Chicago 39
Warsaw 39
Nuremberg 38
Toronto 37
Stockholm 35
San Diego 33
Chennai 32
Da Nang 31
Tashkent 31
Amsterdam 29
Belo Horizonte 29
Buffalo 29
Milan 29
Poplar 27
Columbus 25
Falkenstein 25
Brasília 24
Ankara 23
Council Bluffs 23
Mexico City 23
Curitiba 22
Manchester 22
Porto Alegre 22
San Francisco 22
Boston 20
Den Haag 19
Guayaquil 19
Campinas 18
Dhaka 18
Haiphong 18
New Delhi 18
Ottawa 18
Amman 17
Hải Dương 17
Jeddah 17
Medellín 17
Nairobi 17
Quito 17
Riyadh 17
Caracas 16
Falls Church 16
Guangzhou 16
Totale 21.583
Salva come PNG Salva come JPEG
Nome #
Fisiopatologia dell'emostasi 528
PIASTRINE TRASFETTATE CON MATERIALE GENETICO ESOGENO E MICROPARTICELLE DERIVATE DA DETTE PIASTRINE TRASFETTATE, METODO PER LA LORO PREPARAZIONE E LORO USI. 268
Activation of phospholipase A2 and B-thromboglobulin release in human platelets: comparative effects of thrombin and fluoroaluminate stimulation. 180
Activation of human platelet phospholipase A2 induced by phisiological agonist or fluoroaluminate: effec of inhibitors of protein kinases 178
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. 151
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study. 148
5-ASA-glutamate protects rats from inflammaory bowel disease induced by intracolonic administration of trinitrobenzensulfonic acid. 147
Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management 147
Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients 145
Impact of Chronic Antiplatelet Therapy prior to Hospitalization on Ischemic and Bleeding Events in Invasively Managed Patients with Acute Coronary Syndromes: The ACUITY Trial 143
Diagnosis of suspected inherited platelet function disorders: results of a worldwide survey. 142
Beta 1-tubulin in human platelets: not simply a structural cell frame. 140
Reperfusion of cerebral artery thrombosis by the GPIb-VWF blockade with the Nanobody ALX-0081 reduces brain infarct size in guinea pigs. 140
A novel congenital dysprothrombinemia leading to defective prothrombin maturation. 139
Albumin prevents TxB2 formation from thrombin-stimulated human platelets by sequestring the liberated arachidonic acid in the extracellular space 138
Misurazione del PAF (fattore attivante le piastrine) nella saliva umana; standardizzazione del metodo 137
Effect of aspirin treatment on abacavir-associated platelet hyperreactivity in HIV-infected patients 135
[Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention]. 134
Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. 134
Abstract 15389: High On-Treatment Platelet Reactivity in Clopidogrel-Treated Patients Undergoing Elective Carotid Stenting: Correlation with Previous Cerebrovascular Events 132
Nitric oxide and its antithrombotic action on the cardiovascular system 130
Interaction with damaged vessel wall in vivo in humans induces platelets to express CD40L resulting in endothelial activation. No effect of aspirin intake. 129
Guida alla terapia antitrombotica curata dalla Federazione Nazionale Centri per la Diagnosi della Trombosi e la Sorveglianza delle Terapie Antitrombotiche (FCSA) 128
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia. 127
Contribution of matrix metalloproteinase 2 to joint destruction in group B Streptococcus-induced murine arthritis. 126
Platelets are essential for leukocyte recruitment in allergic inflammation. 126
Impact of tenofovir versus abacavir on HIV-related endothelial dysfunction. 125
Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy. 124
HIV type 1 infection, and not short-term HAART, indice endothelial dysfunction. 121
Effect of substituted stilbenes on platelet function 121
Comparative evaluation of the fully automated HemosIL®AcuStar ADAMTS13 activity assay vs. ELISA: Possible interference by autoantibodies different from anti ADAMTS-13 121
A novel mechanism regulating human platelet activation by MMP-2-mediated PAR1 biased signaling 120
Germline GATA2 variant disrupting endothelial eNOS cell function and angiogenesis can be restored by c-Jun/AP-1 upregulation 120
A new case of acquired Glanzmann's thrombasthenia: Diagnostic value of flow cytometry. 119
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study 119
C-reactive protein induces expression of matrix metalloproteinase-9: A possible link between inflammation and plaque rupture. 118
Altered platelet function associated with the bronchial hyperresponsiveness accompanying nocturnal asthma 118
Search for SARS-CoV-2 RNA in platelets from COVID-19 patients 118
Activation of phospholipase A2 and ß-thromboglobulin release in human platelets stimulated with thrombin and fluoro aluminate 117
Allergen induces the migration of platelets to lung tissue in allergic asthma. 117
Diagnosis of platelet-type von Willebrand disease by flow cytometry. 116
A comparison of lupus anticoagulant-positive patients with clinical picture of antiphospholipid syndrome and those without. 116
Defective platelet beta-N-Acetyl hexosaminidase content and release in chronic myeloproliferative disorders 115
Dominant inheritance of a novel integrin beta3 mutation associated with a hereditary macrothrombocytopenia and platelet dysfunction in two Italian families. 114
In vivo platelet activation and platelet hyperreactivity in abacavir-treated HIV-infected patients. 114
Cloricromene inhibits G-Protein mediated activation of phospholipase A2 in human platelets 113
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 113
The european hematology association roadmap for european hematology research: A consensus document 113
RhoA signaling through platelet P2Y1 receptor controls leukocyte recruitment in allergic mice. 112
Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation 112
A novel nitric oxide-releasing statin derivative exerts and antiplatelet/antithrombotic activity and inhibits tissue factor expression. 112
Acquired von Willebrand syndrome type 2A in a JAK2-positive essential thrombocythaemia-affected member of a large von Willebrand disease family with a novel autosomal dominant A1716P mutation. 112
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML 110
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. 110
Cytoskeletal perturbation leads to platelet dysfunction and thrombocytopenia in variant forms of Glanzmann thrombasthenia 110
AB0952 Intra-articular low molecular weight hyaluronate reduces platelet influx and matrix metalloproteinase-2 levels in synovial fluid of patients with knee osteoarthritis 110
Nitric oxide-donating aspirin (NCX 4016): an overview of its pharmacological properties and clinical perspectives. 109
Tardive gestosis: clinical observations. 109
Mechanisms of thrombocytopenia in platelet-type von Willebrand disease 109
Effect of First Long-Term Training on Whole Blood Count and Blood Clotting Parameters in Thoroughbreds 109
Choline plasmalogen biosynthesis by transmethylation in human platelets 108
Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant. 107
Effect of cloricromene on intermittent claudication. A randomized double-blind, placebo controlled trial in patients treated with aspirin: effect on claudication distance and quality of life 107
A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders 107
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. 106
Anti-platelet therapy: phosphodiesterase inhibitors. 106
Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets 105
Assessment of occlusion of the vascular access in patients on chronic hemodialysis: comparison of physical examination with continuous-wave doppler ultrasound. 105
Anti-platelet treatments in cancer: Basic and clinical research 105
In vitro effect of anti-β2 glycoprotein I antibodies on P-selectin expression: a marker of platelet activation 104
Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis. 104
A dichotomy in platelet activation: Evidence of different functional platelet responses to inflammatory versus haemostatic stimuli 104
The release of arachidonic acid (AA ) by human platelets stimulated by fluoroaluminate and low concetration of collagene potentiated by inhibitors of protein kinase C (PKC). 103
Down-regulation of fluoroaluminate-induced release of arachidonic acid by protein kinase C is calcium-dependent and not related to secretory phospholipase A2 103
Platelets contribute to the accumulation of matrix metalloproteinase type 2 in synovial fluid in osteoarthritis 103
Association of Neutrophil Activation, More Than Platelet Activation, with Thrombotic Complications in Coronavirus Disease 2019 103
Arterite temporale occulta: contributo casistico e revisione della letteratura 102
Curated disease-causing genes for bleeding, thrombotic, and platelet disorders: Communication from the SSC of the ISTH. 102
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC 102
Selective cytochrome c displacement by phosphate and Ca2+ in brain mitochondria 101
Heparin in the prophylaxis and treatment of venous thromboembolism and other thrombotic diseases. 101
Prevalence of thrombophilic genetic mutations in patients undergoing thrombotic events while on oral anticoagulants a case-control study 101
Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data 100
ABO Blood Group and Inhibitor Risk in Severe Hemophilia A Patients: A Study from the Italian Association of Hemophilia Centers 100
Gestational diabetes mellitus is associated with in vivo platelet activation and platelet hyperreactivity 99
Platelet thromboxane A2 receptor number and function in normal and in hypertensive pregnancy. 99
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 99
Acetylsalicylic acid, BM 13.177 and picotamide improve the survival of endotoxin-infused rabbits 99
Eltrombopag in preparation for surgery in patients with severe MYH9-related thrombocytopenia. 99
Megakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: a mechanism for regulating synthetic events. 99
[Occult temporal arteritis. Case reports and review of the literature]. 99
Effect of nitric oxide-donating agents on human monocyte cyclooxygenase-2. 98
Apparent genotype-phenotype mismatch in a patient with MYH9-related disease: when the exception proves the rule. 98
Emergency management in patients with haemophilia A and inhibitors on prophylaxis with emicizumab: AICE practical guidance in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET 98
Inherited disorders and gene regulation of platelet signal transduction: the picture is expanding. 97
Prevalence of hemostatic alterations in patients with recurrent spontaneous subconjunctival hemorrhage 97
A novel variant Glanzmann thrombasthenia due to co-inheritance of a loss- and a gain-of-function mutation of ITGB3: evidence of a dominant effect of gain-of-function mutations. 97
Major bleeding in patients undergoing PCI and triple or dual antithrombotic therapy: a parallel-cohort study. 97
MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. 96
Peripheral arteriopathy: effects of cloricromene on claudication and quality of life, a randomized double blind,,placebo controlled trial in patients treated with aspirin 96
Totale 12.144
Salva come PNG Salva come JPEG
Categoria #
all - tutte 166.742
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 166.742
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.121 0 630 79 129 104 22 37 998 43 113 416 550
2022/20235.964 462 1.152 97 451 461 684 6 253 2.128 19 161 90
2023/20242.648 138 203 121 41 29 13 1.019 52 220 99 412 301
2024/20255.200 55 556 145 195 684 241 188 409 1.195 311 791 430
2025/202611.391 819 737 604 1.493 1.632 984 2.039 470 1.229 876 353 155
2026/2027484 197 287 0 0 0 0 0 0 0 0 0 0
Totale 35.559